Alto Neuroscience (ANRO) Total Liabilities (2023 - 2026)

Alto Neuroscience (ANRO) has 4 years of Total Liabilities data on file, last reported at $32.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities changed 0.22% year-over-year to $32.9 million; the trailing twelve-month figure through Mar 2026 stood at $32.9 million (changed 0.22% YoY), and the FY2025 full-year result was $33.5 million, up 28.62% from the prior year.
• Total Liabilities declined to $32.9 million in Q1 2026, from $33.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $35.4 million in Q3 2025 to a low of $16.8 million in Q1 2024.
• A 4-year average of $27.3 million and a median of $29.7 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 96.0% in 2025 and increased 0.22% in 2026, its largest moves.
• Tracing ANRO's Total Liabilities over 4 years: stood at $16.8 million in 2023, then jumped by 55.04% to $26.1 million in 2024, then climbed by 28.62% to $33.5 million in 2025, then decreased by 1.96% to $32.9 million in 2026.
• Business Quant data shows ANRO's Total Liabilities at $32.9 million in Q1 2026, $33.5 million in Q4 2025, and $35.4 million in Q3 2025.